Chonex
9 employees on LinkedIn · 2 known investors
Find your way into Chonex
Sign up to see every warm intro you have to Chonex
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chonex team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CHONEX develops insect-derived biological products that enhance soil health, plant nutrition, and crop resilience to address challenges including salinity, drought, heat, and nutrient deficiency. The company serves growers by improving root systems and nitrogen use efficiency through a scalable closed-loop biological platform.
Founders & leadership
ML

Michael LynchFounder and CEOMichael Lynch is founder and CEO of CHONEX, which develops insect-derived biological products to enhance soil health and crop resilience. He has held leadership roles in agriculture, manufacturing, and rural community initiatives.
Investors · 2
Funding
SEC filings, press & company announcements$5.8M disclosed across 1 of 2 rounds · 2022–2024
- $5.8Mseed roundJun 2022 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Chonex do?
- CHONEX develops insect-derived biological products that enhance soil health, plant nutrition, and crop resilience to address challenges including salinity, drought, heat, and nutrient deficiency. The company serves growers by improving root systems and nitrogen use efficiency through a scalable closed-loop biological platform.
- Who founded Chonex?
- Chonex was founded by Michael Lynch.
- Who are Chonex's investors?
- Chonex's investors include Bonaventure Capital, Innovation Depot.
- How much funding has Chonex raised?
- Chonex has disclosed $5.8M raised across 1 of its 2 known rounds.

